CDC panel votes to add meningitis booster dose

CHICAGO, Oct 27 (BestGrowthStock) – A panel of federal vaccine
experts narrowly voted to add a booster dose of a meningitis
vaccine to teens at age 16.

The Advisory Committee on Immunization Practices voted 6-5
on Wednesday to add a booster dose of the vaccine at age 16 to
address waning immunity among older teens against meningococcal
bacteria that causes meningitis. Three members abstained.

The CDC already recommends routine meningitis vaccination
beginning at age 11. The vote affects Sanofi Aventis (SASY.PA: ),
maker of a vaccine called Menactra, and Novartis (NOVN.VX: ),
which in February won U.S. approval for its vaccine called
Menveo to protect people aged 11 to 55.

The committee advises the U.S. Centers for Disease Control
and Prevention.
(Reporting by Julie Steenhuysen; Editing by Lisa Von Ahn)

CDC panel votes to add meningitis booster dose